Report Categories
View AllRecent Articles
View All
Can Revelation Biosciences Revb Stock Reach New Highs Price At 1.19 Up 1.70 20260328
Federal Reserve Loses Impetus for Rate Cuts Amid Sticky Inflation
April Jobs Report Signals Cooling Yet Resilient Labor Market
SpaceX IPO Speculation Nvidia Earnings Outlook and Bezos AI Bubble Comments Morning Market Roundup
US Payrolls Surge Past Expectations in April Though Underlying Concerns Persist
Rubio Moves to Calm NATO Allies Amid Conflicting Signals on US Troop Deployments to Poland
Solaris Energy Infrastructure Completes Nearly 2 Billion Financing to Fuel Expansion
Nyxoah Q1 2026 Earnings NarrowerThanExpected Loss Highlights Continued Progress
NAUT Q1 2026 Earnings Narrowed Losses Beat Estimates Amid Platform Progress
HUBS Q1 2026 Earnings Earnings Beat Expectations with 8 Surprise
GOTU Q4 2025 Earnings EPS Beats Estimates Stock Declines Amid Ongoing Challenges
SPRY Q1 2026 Earnings EPS Miss and PreRevenue Status Weigh on Shares as Neffy Launch Awaited
GPCR Q1 2026 Earnings Smaller Loss Than Expected as Pipeline Advances
GENB Q1 2026 Earnings Wider Loss Stings but Pipeline Progress Lifts Shares
FICO Q1 2026 Earnings EPS Surges 1165 Above Estimates Shares Rise
FFBC Q1 2026 Earnings EPS Surpasses Estimates Highlighting Solid Operational Performance
NPCE Q1 2026 Earnings Narrower Loss Beats Estimates Stock Gains
Vivani Medical Q1 2026 Earnings Slight EPS Beat Signals Progress Despite No Revenue